![Nicolas Mourier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicolas Mourier
Chief Executive Officer at Approach SAS
Profile
Nicolas Mourier is currently the Chief Executive Officer at Approach SAS since 2010.
Prior to this, he worked as the Director-Product Development at Peptimmune, Inc. from 2008 to 2011.
He also held positions as Principal at Johnson Matthey, Inc. and Wolfe Laboratories, Inc. Dr. Mourier holds a doctorate degree from Emory University and Université d'Aix-Marseille.
Nicolas Mourier active positions
Companies | Position | Start |
---|---|---|
Approach SAS
![]() Approach SAS Specialty StoresRetail Trade Approach SASU markets outdoor and sports equipments. The company was founded on December 4, 2006 and is headquartered in Valence, France. | Chief Executive Officer | 2010-09-17 |
Former positions of Nicolas Mourier
Companies | Position | End |
---|---|---|
Peptimmune, Inc.
![]() Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Corporate Officer/Principal | 2011-10-26 |
Wolfe Laboratories, Inc.
![]() Wolfe Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Wolfe Laboratories, Inc. operates as a contract research organization which provides integrated drug development solutions to the biopharmaceutical industry. It offers small molecule drug development, biologics development, and antibody-drug conjugates development services. The company was founded by Janet Wolfe in 1999 and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
Johnson Matthey, Inc.
![]() Johnson Matthey, Inc. Wholesale DistributorsDistribution Services Johnson Matthey, Inc. manufactures pharmaceutical ingredients. It provides research and development services for the pharmaceutical industry. The firm manufactures and supplies photovoltaic cell materials, photovoltaic dyes, and photovoltaic cells. The company is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Training of Nicolas Mourier
Emory University | Doctorate Degree |
Université d'Aix-Marseille | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Peptimmune, Inc.
![]() Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Health Technology |
Johnson Matthey, Inc.
![]() Johnson Matthey, Inc. Wholesale DistributorsDistribution Services Johnson Matthey, Inc. manufactures pharmaceutical ingredients. It provides research and development services for the pharmaceutical industry. The firm manufactures and supplies photovoltaic cell materials, photovoltaic dyes, and photovoltaic cells. The company is headquartered in Wayne, PA. | Distribution Services |
Wolfe Laboratories, Inc.
![]() Wolfe Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Wolfe Laboratories, Inc. operates as a contract research organization which provides integrated drug development solutions to the biopharmaceutical industry. It offers small molecule drug development, biologics development, and antibody-drug conjugates development services. The company was founded by Janet Wolfe in 1999 and is headquartered in Woburn, MA. | Health Technology |
Approach SAS
![]() Approach SAS Specialty StoresRetail Trade Approach SASU markets outdoor and sports equipments. The company was founded on December 4, 2006 and is headquartered in Valence, France. | Retail Trade |
- Stock Market
- Insiders
- Nicolas Mourier